207 related articles for article (PubMed ID: 32123236)
1. A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation.
Elbakary B; Badhan RKS
Sci Rep; 2020 Mar; 10(1):3788. PubMed ID: 32123236
[TBL] [Abstract][Full Text] [Related]
2. In vitro porcine blood-brain barrier model for permeability studies: pCEL-X software pKa(FLUX) method for aqueous boundary layer correction and detailed data analysis.
Yusof SR; Avdeef A; Abbott NJ
Eur J Pharm Sci; 2014 Dec; 65():98-111. PubMed ID: 25239510
[TBL] [Abstract][Full Text] [Related]
3. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C
Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068
[TBL] [Abstract][Full Text] [Related]
4. A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells.
Patabendige A; Skinner RA; Morgan L; Abbott NJ
Brain Res; 2013 Jul; 1521():16-30. PubMed ID: 23603406
[TBL] [Abstract][Full Text] [Related]
5. Real-time acquisition of transendothelial electrical resistance in an all-human,
Maherally Z; Fillmore HL; Tan SL; Tan SF; Jassam SA; Quack FI; Hatherell KE; Pilkington GJ
FASEB J; 2018 Jan; 32(1):168-182. PubMed ID: 28883042
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance.
Patabendige A; Skinner RA; Abbott NJ
Brain Res; 2013 Jul; 1521():1-15. PubMed ID: 22789905
[TBL] [Abstract][Full Text] [Related]
7. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise.
Haorah J; Heilman D; Knipe B; Chrastil J; Leibhart J; Ghorpade A; Miller DW; Persidsky Y
Alcohol Clin Exp Res; 2005 Jun; 29(6):999-1009. PubMed ID: 15976526
[TBL] [Abstract][Full Text] [Related]
8. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
Wang YI; Abaci HE; Shuler ML
Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
[TBL] [Abstract][Full Text] [Related]
9. Identification of neuronal and angiogenic growth factors in an in vitro blood-brain barrier model system: Relevance in barrier integrity and tight junction formation and complexity.
Freese C; Hanada S; Fallier-Becker P; Kirkpatrick CJ; Unger RE
Microvasc Res; 2017 May; 111():1-11. PubMed ID: 27988246
[TBL] [Abstract][Full Text] [Related]
10. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I
Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978
[TBL] [Abstract][Full Text] [Related]
11. Co-culture based blood-brain barrier in vitro model, a tissue engineering approach using immortalized cell lines for drug transport study.
Zhang Z; McGoron AJ; Crumpler ET; Li CZ
Appl Biochem Biotechnol; 2011 Jan; 163(2):278-95. PubMed ID: 20652765
[TBL] [Abstract][Full Text] [Related]
12. Primary porcine brain microvascular endothelial cells: biochemical and functional characterisation as a model for drug transport and targeting.
Smith M; Omidi Y; Gumbleton M
J Drug Target; 2007 May; 15(4):253-68. PubMed ID: 17487694
[TBL] [Abstract][Full Text] [Related]
13. An immortalised astrocyte cell line maintains the in vivo phenotype of a primary porcine in vitro blood-brain barrier model.
Cantrill CA; Skinner RA; Rothwell NJ; Penny JI
Brain Res; 2012 Oct; 1479():17-30. PubMed ID: 22940232
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways.
Lohmann C; Krischke M; Wegener J; Galla HJ
Brain Res; 2004 Jan; 995(2):184-96. PubMed ID: 14672808
[TBL] [Abstract][Full Text] [Related]
15. Initial contact of glioblastoma cells with existing normal brain endothelial cells strengthen the barrier function via fibroblast growth factor 2 secretion: a new in vitro blood-brain barrier model.
Toyoda K; Tanaka K; Nakagawa S; Thuy DH; Ujifuku K; Kamada K; Hayashi K; Matsuo T; Nagata I; Niwa M
Cell Mol Neurobiol; 2013 May; 33(4):489-501. PubMed ID: 23385422
[TBL] [Abstract][Full Text] [Related]
16. Chlorpyrifos, permethrin and cyfluthrin effect on cell survival, permeability, and tight junction in an in-vitro model of the human blood-brain barrier (BBB).
Deepika D; Kumar S; Bravo N; Esplugas R; Capodiferro M; Sharma RP; Schuhmacher M; Grimalt JO; Blanco J; Kumar V
Neurotoxicology; 2022 Dec; 93():152-162. PubMed ID: 36167171
[TBL] [Abstract][Full Text] [Related]
17. Cerebral hypoxia/ischemia selectively disrupts tight junctions complexes in stem cell-derived human brain microvascular endothelial cells.
Page S; Munsell A; Al-Ahmad AJ
Fluids Barriers CNS; 2016 Oct; 13(1):16. PubMed ID: 27724968
[TBL] [Abstract][Full Text] [Related]
18. The blood-brain barrier studied in vitro across species.
Thomsen MS; Humle N; Hede E; Moos T; Burkhart A; Thomsen LB
PLoS One; 2021; 16(3):e0236770. PubMed ID: 33711041
[TBL] [Abstract][Full Text] [Related]
19. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells.
Zhu H; Wang Z; Xing Y; Gao Y; Ma T; Lou L; Lou J; Gao Y; Wang S; Wang Y
J Ethnopharmacol; 2012 Jun; 141(2):714-20. PubMed ID: 21920425
[TBL] [Abstract][Full Text] [Related]
20. Functional brain-specific microvessels from iPSC-derived human brain microvascular endothelial cells: the role of matrix composition on monolayer formation.
Katt ME; Linville RM; Mayo LN; Xu ZS; Searson PC
Fluids Barriers CNS; 2018 Feb; 15(1):7. PubMed ID: 29463314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
